檢索結果 - Tariq Muzzafar
- Showing 1 - 6 results of 6
-
1
-
2
-
3
-
4
Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial 由 Jason R. Westin, Fuliang Chu, Min Zhang, Luis Fayad, Larry W. Kwak, Nathan Fowler, Jorge Romaguera, Fredrick B. Hagemeister, Michelle A. Fanale, Felipe Samaniego, Lei Feng, Veerabhadran Baladandayuthapani, Zhiqiang Wang, Wencai Ma, Yan-Li Gao, Michael B. Wallace, Luis M. Vence, Laszlo Radvanyi, Tariq Muzzafar, Rinat Rotem‐Yehudar, R. Eric Davis, Sattva S. Neelapu
出版 2013Artigo -
5
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial 由 Nathan Fowler, R. Eric Davis, Seema Rawal, Loretta J. Nastoupil, Fredrick B. Hagemeister, Peter McLaughlin, Larry W. Kwak, Jorge Romaguera, Michelle A. Fanale, Luis Fayad, Jason R. Westin, Jatin J. Shah, Robert Z. Orlowski, Michael Wang, Francesco Turturro, Yasuhiro Oki, Linda Claret, Lei Feng, Veerabhadran Baladandayuthapani, Tariq Muzzafar, Kenneth Y. Tsai, Felipe Samaniego, Sattva S. Neelapu
出版 2014Artigo -
6
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study 由 Mohamed A. Kharfan‐Dabaja, Monzr M. Al Malki, Uday Deotare, Renju Raj, Najla El‐Jurdi, Navneet S. Majhail, Mohamad Cherry, Qaiser Bashir, Justin Darrah, Taiga Nishihori, Hassan Sibai, Mehdi Hamadani, Marcos de Lima, Aaron T. Gerds, George B. Selby, Muzaffar H. Qazilbash, Stephen J. Forman, Ernesto Ayala, Jeffrey H. Lipton, Parameswaran Hari, Tariq Muzzafar, Ling Zhang, Horatiu Olteanu, Janelle Perkins, Lubomir Sokol, Ambuj Kumar, Sairah Ahmed
出版 2017Artigo
相關主題
Medicine
Biology
Immunology
Internal medicine
Oncology
Clinical trial
Lymphoma
Pathology
Clinical endpoint
Flow cytometry
Gastroenterology
Genetics
Immunophenotyping
Leukemia
Rituximab
Adenocarcinoma
Adverse effect
Anaplastic large-cell lymphoma
Anaplastic lymphoma kinase
Antibody
B cell
Bone marrow
CD30
CD81
Cancer
Cancer research
Chromosome
Confidence interval
Environmental health
Fluorescence in situ hybridization